drugset / Trial / NCT01675895

Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration

NCT01675895

Phase 4 Completed 40 enrolled Diskapi Teaching and Research Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The main objective was to test the hypothesis that adding lidocaine to hyperbaric levobupivacaine could change the duration of levobupivacaine spinal block.

Timeline

Start
2009-07
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobupivacaine Other / unclassified 6.75 mg Intrathecal
Subject Lidocaine Other / unclassified 2 % Intrathecal